Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
23.85    -0.30 (-1.24%)
Bid:
23.80
Ask:
23.90
Spread: 0.10 (0.42%)
Market Cap: £443.87m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

Transaction in Own Shares

23 Sep 2024 07:00

RNS Number : 1348F
EnQuest PLC
23 September 2024
 

FOR IMMEDIATE RELEASE 23 September 2024

 

ENQUEST PLC ("EnQuest" or "the Company")

TRANSACTIONS IN OWN SHARES

EnQuest PLC (the "Company") announces that, on 20 September 2024, it purchased the following number of its ordinary shares of 5 pence each (the "Ordinary Shares") through Merrill Lynch International ("Merrill Lynch"). Such purchase was effected pursuant to the instructions issued by the Company in accordance with the share repurchase arrangements entered into with Merrill Lynch, as announced on 29 April 2024.

Aggregated information of Ordinary Shares purchased on 20 September 2024 according to each trading venue:

Venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share (GBp)

Highest price paid per share (GBp)

London Stock Exchange

11.40

599,000

11.20

11.60

Chi-X

11.40

30,032

11.30

11.54

BATS

11.35

14,221

11.30

11.48

Turquoise

-

0

-

-

Total (all venues)

11.39

643,253

11.20

11.60

 

Since 29 April 2024, the Company has purchased 33,295,887 Ordinary Shares at a cost (including dealing and associated costs) of £4,489,790.95. Of those shares, 25,000,000 Ordinary Shares have been retained in Treasury and will be issued in due course to the Company's Employee Benefit Trust and 8,295,887 Ordinary Shares have been purchased for cancellation.

Following the cancellation of the purchased shares, there will be 1,907,628,452 Ordinary Shares in issue and 25,000,000 Shares in Treasury. The total voting rights in the Company will accordingly be 1,882,628,452. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

A full breakdown of the individual trades made by Merrill Lynch on behalf of the Company as part of the share repurchase programme is attached to this document.

Attachment: http://www.rns-pdf.londonstockexchange.com/rns/1348F_1-2024-9-21.pdf

 

LEI: 2138008LJU6WFQWOXJ73

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

Enquiries:

 

EnQuest plc +44 (0)20 7925 4900

Kate Christ, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBXGDCUDDDGSB
Date   Source Headline
3rd Feb 20227:00 amRNSOperations update
7th Jan 20229:32 amRNSDirector/PDMR Shareholding
22nd Dec 20218:36 amRNSDirectorate Change
20th Dec 20213:56 pmRNSDirector/PDMR Shareholding
1st Dec 202110:44 amRNSHolding(s) in Company
26th Nov 202110:44 amRNSHolding(s) in Company
24th Nov 20211:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:23 pmRNSDirector/PDMR Shareholding
18th Nov 20217:00 amRNSOperations update
8th Nov 20213:59 pmRNSHolding(s) in Company
29th Oct 20211:37 pmRNSHolding(s) in Company
25th Oct 20218:05 amRNSRe-admission of Ordinary shares
22nd Oct 20213:02 pmRNSCompletion of Golden Eagle Acquisition
22nd Oct 20211:27 pmRNSHolding(s) in Company
20th Oct 20212:00 pmRNSPublication of Supplementary Prospectus
14th Oct 20217:00 amRNSHolding(s) in Company
5th Oct 20215:07 pmRNSPublication of Supplementary Prospectus
29th Sep 202110:29 amRNSHolding(s) in Company
2nd Sep 20217:00 amRNSHalf-year Results
20th Aug 20213:35 pmRNSHolding(s) in Company
3rd Aug 20217:00 amRNSHolding(s) in Company
30th Jul 20213:22 pmRNSDirector/PDMR Shareholding
29th Jul 202110:18 amRNSHolding(s) in Company
26th Jul 20217:00 amRNSAdmission of New Shares
23rd Jul 202111:21 amRNSResults of Capital Raising and General Meeting
9th Jul 20211:00 pmRNSGeneral Meeting Notice Amendment
6th Jul 20217:00 amRNSBentley transaction completion
30th Jun 20215:12 pmRNSPublication of Combined Circular and Prospectus
30th Jun 20214:17 pmRNSCompletion of Firm Placing and Placing
30th Jun 20217:00 amRNSProposed Firm Placing and Placing and Open Offer
25th May 202110:00 amRNSPayments to governments
12th May 20214:26 pmRNSAGM Statement
12th May 20217:00 amRNSOperations update
5th May 20214:21 pmRNSDirector/PDMR Shareholding
26th Apr 20212:11 pmRNSDirector/PDMR Shareholding
26th Apr 20217:00 amRNSAgreement to acquire Bentley discovery
19th Apr 20213:34 pmRNSDirector/PDMR Shareholding
16th Apr 202110:00 amRNSHolding(s) in Company
15th Apr 20214:31 pmRNSHolding(s) in Company
15th Apr 20214:00 pmRNSAnnual Financial Report
30th Mar 20212:34 pmRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSResults for the year ended 31 December 2020
2nd Mar 20218:00 amRNSHolding(s) in Company
25th Feb 20219:00 amRNSHolding(s) in Company
25th Feb 20217:00 amRNSEagle discovery farm-down
23rd Feb 202111:41 amRNSHolding(s) in Company
22nd Feb 20219:00 amRNSHolding(s) in Company
19th Feb 20213:21 pmRNSHolding(s) in Company
18th Feb 20213:09 pmRNSAdmission to trading
18th Feb 20219:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.